Bicara Therapeutics
Vijay Kuchroo AN Institute Member, Broad Institute of MIT and Harvard. He is the inventor on 25 patents, founder of five biotech companies, and member of numerous scientific advisory boards, including those of Biocon, Pfizer, Novartis, and GSK. Vijay is also the founding Director of the Evergrande Center for Immunologic Diseases at Harvard Medical School and Brigham and Women’s Hospital and the Kuchroo Laboratory, a leader in research that created the basis for describing the TIM family of genes. He holds a Ph.D. in Pathology from the University of Queensland, Brisbane Australia; a bachelor’s degree from the College of Veterinary Medicine, Hisar, India.
This person is not in the org chart
This person is not in any offices
Bicara Therapeutics
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of immunotherapy. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy.